Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001224
Filing Date
2025-05-13
Accepted
2025-05-13 16:01:39
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atxs-20250331x10q.htm   iXBRL 10-Q 1186879
2 EX-31.1 atxs-20250331xex31d1.htm EX-31.1 12071
3 EX-31.2 atxs-20250331xex31d2.htm EX-31.2 12049
4 EX-32.1 atxs-20250331xex32d1.htm EX-32.1 7617
  Complete submission text file 0001410578-25-001224.txt   5859638

Data Files

Seq Description Document Type Size
5 EX-101.SCH atxs-20250331.xsd EX-101.SCH 40083
6 EX-101.CAL atxs-20250331_cal.xml EX-101.CAL 40298
7 EX-101.DEF atxs-20250331_def.xml EX-101.DEF 172917
8 EX-101.LAB atxs-20250331_lab.xml EX-101.LAB 380092
9 EX-101.PRE atxs-20250331_pre.xml EX-101.PRE 271990
70 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20250331x10q_htm.xml XML 1019276
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 25939817
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)